Vol 8 Issue 6

CELL AND GENE THERAPY INSIGHTS

July 2022 Issue

Vol 8 Issue 6

Download PDF

Featuring

Issue Spotlight: Global regulatory update
Driving the digitization of cell and gene therapy supply chains 2022
Other articles
Webinar

SPOTLIGHT

Global regulatory update
Alexis Cockroft
Guest Editor:
Alexis Cockroft, Regulatory Consultant at Lex Regulatory Ltd

Interview

Inside the UK’s brave new world of ATMP regulatory innovation

Inside the UK’s brave new world of ATMP regulatory innovation

Jacqueline Barry
1 August 2022
Read
Evolving ATMP regulations in the EU & UK, & the role of the Qualified Person

Evolving ATMP regulations in the EU & UK, & the role of the Qualified Person

David Caulfield
10 July 2022
Read
Trends in academic ATMP development & manufacture in Europe

Trends in academic ATMP development & manufacture in Europe

Pauline Meij
10 July 2022
Read
Regulatory learnings for the next wave of cellular immuno-oncology agents

Regulatory learnings for the next wave of cellular immuno-oncology agents

Robert Pietrusko
26 June 2022
Read
Cell & gene therapy R&D & regulatory evolution in the United Arab Emirates

Cell & gene therapy R&D & regulatory evolution in the United Arab Emirates

Asawari Bapat
24 June 2022
Read

Viewpoint

Recent gene-editing guidance from FDA – clarifies some gene-editing development questions with room for additional recommendations

Recent gene-editing guidance from FDA – clarifies some gene-editing development questions with room for additional recommendations

Kathleen Candando, Karl Whitney
10 July 2022
Read

Regulatory perspective

A need for a novel regulatory framework for individualized neoantigen-specific therapies

A need for a novel regulatory framework for individualized neoantigen-specific therapies

Amy Hardwick, Kathleen Francissen
29 June 2022
Read

Supply Chain FOCUS

Driving the digitization of cell and gene therapy supply chains 2022

FastFacts

Cell & Gene therapy supply chain orchestration explained

Cell & Gene therapy supply chain orchestration explained

17 July 2022
Read

Commentary

Critical success factors to consider before digitizing a cell & gene therapy supply chain

Critical success factors to consider before digitizing a cell & gene therapy supply chain

August Zepka, Charles Wilfong
23 July 2022
Read

Innovator Insight

Optimizing and standardizing the cryopreservation of cellular samples: new data and insights from the UK’s Advanced Therapy Treatment Centres network programme

Optimizing and standardizing the cryopreservation of cellular samples: new data and insights from the UK’s Advanced Therapy Treatment Centres network programme

Sandeep Kumar, Julie Meneghel
18 September 2022
Read

Journal articles

Research Article

Consideration of quality by design principles in the use of sterilizing grade filters for clarification and final sterile filtration in adeno-associated virus applications

Consideration of quality by design principles in the use of sterilizing grade filters for clarification and final sterile filtration in adeno-associated virus applications

Morven McAlister, Alexander Lambropoulos
30 August 2022
Read

Innovator Insight

Manufacturing considerations underpinning viral and non-viral platform selection

Manufacturing considerations underpinning viral and non-viral platform selection

A Hagerman, A Noyes, V Slepushkin et al.
30 July 2022
Read

Poster

The digital revolution: technological innovations to enable automation in cell therapy manufacturing

The digital revolution: technological innovations to enable automation in cell therapy manufacturing

Bruce Greenwald, Sean Chang, Krish Roy
13 July 2022
Read

Webinars